Randomized Multi Center(隨機多中心)到底是什麼？
Randomized Multi Center 隨機多中心 - This was a secondary analysis of the OPTIMAL trial, a randomized multi-centered study comparing outcomes of sacrospinous ligament fixation and transvaginal uterosacral ligament suspension (USLS). [1] A prospective randomized multi-center clinical trial was designed to evaluate the role of DCE-MRI based RT dose escalation in poor prognosis HNC. [2] However, in the past few years, a huge array of coordinated but randomized multi-center clinical studies were performed and various detailed insight investigations have been done, and substantial clinical guidelines have become available. [3] The publication of multiple new high-quality randomized multi-center trials in the area of AF management and the rapidly evolving technological progress in terms of diagnostic possibilities and catheter ablation in recent years demanded a revision of the previous ESC AF Guidelines from 2016. [4] Ivermectin as an adjunct treatment for hospitalized adult COVID-19 patients: a randomized multi-center clinical trial. [5] This was a prospective, randomized multi-center trial comparing St. [6] METHODS The SPINE CARE (Spine Pain Intervention to Enhance Care Quality And Reduce Expenditure) trial is a cluster-randomized multi-center pragmatic clinical trial designed to evaluate the clinical effectiveness and healthcare utilization of two interventions for primary care patients with acute and subacute spine pain. [7] Methods: A Phase III randomized multi-center observer-blind parallel-group clinical trial was conducted. [8] And, perhaps most broadly, developing a system for treating inconsistencies would stand to improve the qualities of both 1) real world evidence-based studies (retrospective), on the one hand, and 2) placebo-controlled, randomized multi-center clinical trials (prospective), on the other hand. [9]這是對 OPTIMAL 試驗的二次分析，該試驗是一項比較骶棘韌帶固定和經陰道子宮骶韌帶懸吊 (USLS) 的結果的隨機多中心研究。 [1] 一項前瞻性隨機多中心臨床試驗旨在評估基於 DCE-MRI 的 RT 劑量遞增在預後不良的 HNC 中的作用。 [2] 然而，在過去的幾年裡，進行了大量協調但隨機的多中心臨床研究，並進行了各種詳細的洞察力調查，並獲得了大量的臨床指南。 [3] 近年來在 AF 管理領域發表的多項新的高質量隨機多中心試驗以及在診斷可能性和導管消融方面迅速發展的技術進步要求從 2016 年開始修訂以前的 ESC AF 指南。 [4] 伊維菌素作為住院成人 COVID-19 患者的輔助治療：一項隨機多中心臨床試驗。 [5] 這是一項前瞻性、隨機多中心試驗，比較 St. [6] 方法 SPINE CARE（提高護理質量和減少支出的脊柱疼痛干預）試驗是一項集群隨機多中心實用臨床試驗，旨在評估兩種干預措施對急性和亞急性脊柱疼痛初級保健患者的臨床有效性和醫療保健利用率。 [7] 方法：進行III期隨機多中心觀察者盲平行組臨床試驗。 [8] 而且，也許從最廣泛的意義上講，開發一個治療不一致的系統將有助於提高兩個方面的質量：1）一方面，現實世界的循證研究（回顧性），2）安慰劑對照的隨機多中心臨床試驗（預期），另一方面。 [9]